Comparing INVO Fertility (NASDAQ:IVF) and Nutex Health (NASDAQ:NUTX)

INVO Fertility (NASDAQ:IVF) and Nutex Health (NASDAQ:NUTX) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, risk, institutional ownership, earnings and profitability.

Earnings and Valuation

This table compares INVO Fertility and Nutex Health”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
INVO Fertility	$6.84 million	0.36	-$25.13 million	($33.83)	-0.03
Nutex Health	$875.26 million	1.64	$70.79 million	$25.47	8.21

Nutex Health has higher revenue and earnings than INVO Fertility. INVO Fertility is trading at a lower price-to-earnings ratio than Nutex Health, indicating that it is currently the more affordable of the two stocks.

Insider and Institutional Ownership

12.0% of INVO Fertility shares are owned by institutional investors. Comparatively, 5.3% of Nutex Health shares are owned by institutional investors. 0.4% of INVO Fertility shares are owned by company insiders. Comparatively, 44.7% of Nutex Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for INVO Fertility and Nutex Health, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
INVO Fertility	1	0	0	1	2.50
Nutex Health	0	1	2	1	3.00

INVO Fertility presently has a consensus price target of $20.00, suggesting a potential upside of 1,914.10%. Nutex Health has a consensus price target of $317.50, suggesting a potential upside of 51.88%. Given INVO Fertility’s higher probable upside, equities research analysts clearly believe INVO Fertility is more favorable than Nutex Health.

Volatility and Risk

INVO Fertility has a beta of 2.34, indicating that its stock price is 134% more volatile than the S&P 500. Comparatively, Nutex Health has a beta of 0.28, indicating that its stock price is 72% less volatile than the S&P 500.

Profitability

This table compares INVO Fertility and Nutex Health’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
INVO Fertility	-116.29%	-85.54%	-31.05%
Nutex Health	21.25%	39.74%	18.91%

Summary

Nutex Health beats INVO Fertility on 11 of the 14 factors compared between the two stocks.

About INVO Fertility

INVO Bioscience, Inc., together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman’s body. The company was founded in 2007 and is based in Sarasota, Florida.

About Nutex Health

Nutex Health Inc. operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management. The Real Estate segment owns and owns and leases land and hospital building. The Hospital segment develops and operates a network of micro-hospitals, specialty hospitals and hospital outpatient departments which offers 24/7 care. It also provides operational and managerial services, including management, billing, collections, human resources and recruiting, legal, accounting, and marketing. In addition, the company offers healthcare services, including emergency room care, inpatient care, and behavioral health, as well as onsite imaging, such as CT scan, X-ray, MRI, ultrasound, etc.; certified and accredited laboratories; and onsite inpatient pharmacies. The company was founded in 2011 and is based in Houston, Texas.